Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

  1. Goetz, M.P.
  2. Martin, M.
  3. Tokunaga, E.
  4. Park, I.H.
  5. Huober, J.
  6. Toi, M.
  7. Stoffregen, C.
  8. Shekarriz, S.
  9. Andre, V.
  10. Gainford, M.C.
  11. Price, G.L.
  12. Johnston, S.
Revista:
Oncologist

ISSN: 1549-490X,  1083-7159

Ano de publicación: 2020

Volume: 25

Número: 9

Páxinas: e1346-e1354

Tipo: Artigo

DOI: 10.1634/THEONCOLOGIST.2020-0084 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus